nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicotine—SLC22A2—Cladribine—multiple sclerosis	0.0772	0.127	CbGbCtD
Nicotine—SLC22A1—Cladribine—multiple sclerosis	0.067	0.11	CbGbCtD
Nicotine—CYP19A1—Betamethasone—multiple sclerosis	0.0632	0.104	CbGbCtD
Nicotine—CYP2E1—Fingolimod—multiple sclerosis	0.063	0.103	CbGbCtD
Nicotine—CYP2A6—Prednisolone—multiple sclerosis	0.0395	0.0648	CbGbCtD
Nicotine—CYP19A1—Dexamethasone—multiple sclerosis	0.0367	0.0603	CbGbCtD
Nicotine—CYP2D6—Fingolimod—multiple sclerosis	0.03	0.0493	CbGbCtD
Nicotine—CYP2E1—Mitoxantrone—multiple sclerosis	0.0296	0.0486	CbGbCtD
Nicotine—CYP2A6—Dexamethasone—multiple sclerosis	0.0233	0.0382	CbGbCtD
Nicotine—CYP1A1—Dexamethasone—multiple sclerosis	0.0199	0.0326	CbGbCtD
Nicotine—CYP3A4—Fingolimod—multiple sclerosis	0.0191	0.0313	CbGbCtD
Nicotine—CYP2C19—Prednisone—multiple sclerosis	0.0154	0.0253	CbGbCtD
Nicotine—CYP2E1—Dexamethasone—multiple sclerosis	0.0154	0.0252	CbGbCtD
Nicotine—CYP2B6—Dexamethasone—multiple sclerosis	0.0152	0.0249	CbGbCtD
Nicotine—CHRNB3—pons—multiple sclerosis	0.0143	0.113	CbGeAlD
Nicotine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0123	0.0202	CbGbCtD
Nicotine—CYP2C8—Dexamethasone—multiple sclerosis	0.0115	0.0188	CbGbCtD
Nicotine—CHAT—pons—multiple sclerosis	0.00994	0.0785	CbGeAlD
Nicotine—CYP2C19—Dexamethasone—multiple sclerosis	0.00963	0.0158	CbGbCtD
Nicotine—CYP3A4—Triamcinolone—multiple sclerosis	0.00933	0.0153	CbGbCtD
Nicotine—CYP3A4—Mitoxantrone—multiple sclerosis	0.00898	0.0147	CbGbCtD
Nicotine—CYP2C9—Dexamethasone—multiple sclerosis	0.00801	0.0131	CbGbCtD
Nicotine—CYP3A4—Betamethasone—multiple sclerosis	0.008	0.0131	CbGbCtD
Nicotine—CYP3A4—Prednisolone—multiple sclerosis	0.0079	0.013	CbGbCtD
Nicotine—CYP3A4—Prednisone—multiple sclerosis	0.00746	0.0122	CbGbCtD
Nicotine—CYP2D6—Dexamethasone—multiple sclerosis	0.00732	0.012	CbGbCtD
Nicotine—CHAT—peripheral nervous system—multiple sclerosis	0.00661	0.0522	CbGeAlD
Nicotine—CHAT—nerve—multiple sclerosis	0.00516	0.0407	CbGeAlD
Nicotine—CYP3A4—Dexamethasone—multiple sclerosis	0.00466	0.00764	CbGbCtD
Nicotine—CHRNB3—brainstem—multiple sclerosis	0.00319	0.0252	CbGeAlD
Nicotine—CHRNA4—peripheral nervous system—multiple sclerosis	0.00286	0.0226	CbGeAlD
Nicotine—CHRNA6—brainstem—multiple sclerosis	0.00267	0.021	CbGeAlD
Nicotine—CHRNA4—nerve—multiple sclerosis	0.00223	0.0176	CbGeAlD
Nicotine—CHAT—brainstem—multiple sclerosis	0.00221	0.0175	CbGeAlD
Nicotine—CHAT—retina—multiple sclerosis	0.00214	0.0169	CbGeAlD
Nicotine—CHRNB3—midbrain—multiple sclerosis	0.00204	0.0161	CbGeAlD
Nicotine—CHRNA5—nervous system—multiple sclerosis	0.00184	0.0145	CbGeAlD
Nicotine—CHRNA5—central nervous system—multiple sclerosis	0.00177	0.014	CbGeAlD
Nicotine—CHRNA6—midbrain—multiple sclerosis	0.0017	0.0134	CbGeAlD
Nicotine—CHRNB3—nervous system—multiple sclerosis	0.00167	0.0132	CbGeAlD
Nicotine—MAOB—nerve—multiple sclerosis	0.00167	0.0132	CbGeAlD
Nicotine—CHRNB3—central nervous system—multiple sclerosis	0.00161	0.0127	CbGeAlD
Nicotine—CHRNB3—cerebellum—multiple sclerosis	0.00157	0.0124	CbGeAlD
Nicotine—CHAT—medulla oblongata—multiple sclerosis	0.00154	0.0122	CbGeAlD
Nicotine—CHRNA3—retina—multiple sclerosis	0.00143	0.0113	CbGeAlD
Nicotine—MAOA—nerve—multiple sclerosis	0.00142	0.0112	CbGeAlD
Nicotine—CHAT—midbrain—multiple sclerosis	0.00141	0.0111	CbGeAlD
Nicotine—CHRNA5—brain—multiple sclerosis	0.00141	0.0111	CbGeAlD
Nicotine—CHRNA6—nervous system—multiple sclerosis	0.0014	0.011	CbGeAlD
Nicotine—CHAT—spinal cord—multiple sclerosis	0.00138	0.0109	CbGeAlD
Nicotine—CHRNA6—central nervous system—multiple sclerosis	0.00134	0.0106	CbGeAlD
Nicotine—CHRNA6—cerebellum—multiple sclerosis	0.00131	0.0104	CbGeAlD
Nicotine—CHRNB3—brain—multiple sclerosis	0.00128	0.0101	CbGeAlD
Nicotine—CHRNB4—nervous system—multiple sclerosis	0.00127	0.01	CbGeAlD
Nicotine—CHRNB4—central nervous system—multiple sclerosis	0.00122	0.00964	CbGeAlD
Nicotine—CHAT—nervous system—multiple sclerosis	0.00116	0.00916	CbGeAlD
Nicotine—CHAT—central nervous system—multiple sclerosis	0.00112	0.00882	CbGeAlD
Nicotine—CHAT—cerebellum—multiple sclerosis	0.00109	0.00862	CbGeAlD
Nicotine—CHRNB2—medulla oblongata—multiple sclerosis	0.00107	0.00843	CbGeAlD
Nicotine—CHRNA6—brain—multiple sclerosis	0.00107	0.00843	CbGeAlD
Nicotine—CHRNB2—midbrain—multiple sclerosis	0.000976	0.0077	CbGeAlD
Nicotine—CHRNB4—brain—multiple sclerosis	0.000969	0.00765	CbGeAlD
Nicotine—CHRNA4—brainstem—multiple sclerosis	0.000957	0.00755	CbGeAlD
Nicotine—CHRNB2—spinal cord—multiple sclerosis	0.000952	0.00752	CbGeAlD
Nicotine—CHRNA7—retina—multiple sclerosis	0.000936	0.00739	CbGeAlD
Nicotine—CHAT—brain—multiple sclerosis	0.000886	0.007	CbGeAlD
Nicotine—CHRNB2—nervous system—multiple sclerosis	0.000802	0.00633	CbGeAlD
Nicotine—CHRNA3—nervous system—multiple sclerosis	0.000778	0.00614	CbGeAlD
Nicotine—CHRNB2—central nervous system—multiple sclerosis	0.000772	0.0061	CbGeAlD
Nicotine—CHRNB2—cerebellum—multiple sclerosis	0.000755	0.00596	CbGeAlD
Nicotine—CHRNA3—central nervous system—multiple sclerosis	0.000749	0.00591	CbGeAlD
Nicotine—CHRNA3—cerebellum—multiple sclerosis	0.000732	0.00578	CbGeAlD
Nicotine—CHRNA2—nervous system—multiple sclerosis	0.000723	0.00571	CbGeAlD
Nicotine—MAOB—brainstem—multiple sclerosis	0.000715	0.00565	CbGeAlD
Nicotine—CHRNA2—central nervous system—multiple sclerosis	0.000696	0.0055	CbGeAlD
Nicotine—CHRNA2—cerebellum—multiple sclerosis	0.000681	0.00537	CbGeAlD
Nicotine—CHRFAM7A—nervous system—multiple sclerosis	0.000629	0.00497	CbGeAlD
Nicotine—CHRNB2—brain—multiple sclerosis	0.000613	0.00484	CbGeAlD
Nicotine—MAOA—brainstem—multiple sclerosis	0.00061	0.00482	CbGeAlD
Nicotine—CHRNA4—midbrain—multiple sclerosis	0.00061	0.00481	CbGeAlD
Nicotine—CHRFAM7A—central nervous system—multiple sclerosis	0.000606	0.00478	CbGeAlD
Nicotine—CHRNA4—spinal cord—multiple sclerosis	0.000595	0.0047	CbGeAlD
Nicotine—CHRNA3—brain—multiple sclerosis	0.000595	0.00469	CbGeAlD
Nicotine—MAOA—retina—multiple sclerosis	0.000589	0.00465	CbGeAlD
Nicotine—CHRNA2—brain—multiple sclerosis	0.000553	0.00436	CbGeAlD
Nicotine—SLC22A5—retina—multiple sclerosis	0.000542	0.00428	CbGeAlD
Nicotine—SLC22A4—spinal cord—multiple sclerosis	0.000528	0.00417	CbGeAlD
Nicotine—CHRNA7—nervous system—multiple sclerosis	0.000508	0.00401	CbGeAlD
Nicotine—CHRNA4—nervous system—multiple sclerosis	0.000501	0.00396	CbGeAlD
Nicotine—MAOB—medulla oblongata—multiple sclerosis	0.000499	0.00394	CbGeAlD
Nicotine—CHRNA7—central nervous system—multiple sclerosis	0.000489	0.00386	CbGeAlD
Nicotine—CHRNA4—central nervous system—multiple sclerosis	0.000483	0.00381	CbGeAlD
Nicotine—CHRFAM7A—brain—multiple sclerosis	0.000481	0.0038	CbGeAlD
Nicotine—CYP2A6—cerebellum—multiple sclerosis	0.000478	0.00377	CbGeAlD
Nicotine—CHRNA4—cerebellum—multiple sclerosis	0.000472	0.00372	CbGeAlD
Nicotine—MAOB—midbrain—multiple sclerosis	0.000456	0.0036	CbGeAlD
Nicotine—MAOB—spinal cord—multiple sclerosis	0.000445	0.00351	CbGeAlD
Nicotine—MAOA—medulla oblongata—multiple sclerosis	0.000425	0.00336	CbGeAlD
Nicotine—SLC22A1—nervous system—multiple sclerosis	0.000424	0.00334	CbGeAlD
Nicotine—SLC22A4—cerebellum—multiple sclerosis	0.000419	0.00331	CbGeAlD
Nicotine—SLC22A1—central nervous system—multiple sclerosis	0.000408	0.00322	CbGeAlD
Nicotine—SLC22A3—nervous system—multiple sclerosis	0.000405	0.0032	CbGeAlD
Nicotine—CYP19A1—nervous system—multiple sclerosis	0.000398	0.00314	CbGeAlD
Nicotine—SLC22A5—medulla oblongata—multiple sclerosis	0.000392	0.00309	CbGeAlD
Nicotine—SLC22A3—central nervous system—multiple sclerosis	0.00039	0.00308	CbGeAlD
Nicotine—MAOA—midbrain—multiple sclerosis	0.000389	0.00307	CbGeAlD
Nicotine—CHRNA7—brain—multiple sclerosis	0.000388	0.00307	CbGeAlD
Nicotine—CYP2A6—brain—multiple sclerosis	0.000388	0.00306	CbGeAlD
Nicotine—CYP19A1—central nervous system—multiple sclerosis	0.000383	0.00303	CbGeAlD
Nicotine—CHRNA4—brain—multiple sclerosis	0.000383	0.00303	CbGeAlD
Nicotine—MAOA—spinal cord—multiple sclerosis	0.000379	0.003	CbGeAlD
Nicotine—MAOB—nervous system—multiple sclerosis	0.000375	0.00296	CbGeAlD
Nicotine—CYP2D6—brainstem—multiple sclerosis	0.000363	0.00286	CbGeAlD
Nicotine—MAOB—central nervous system—multiple sclerosis	0.000361	0.00285	CbGeAlD
Nicotine—SLC22A5—midbrain—multiple sclerosis	0.000358	0.00283	CbGeAlD
Nicotine—MAOB—cerebellum—multiple sclerosis	0.000353	0.00278	CbGeAlD
Nicotine—SLC22A5—spinal cord—multiple sclerosis	0.000349	0.00276	CbGeAlD
Nicotine—SLC22A4—brain—multiple sclerosis	0.00034	0.00268	CbGeAlD
Nicotine—SLC22A1—brain—multiple sclerosis	0.000324	0.00256	CbGeAlD
Nicotine—MAOA—nervous system—multiple sclerosis	0.00032	0.00252	CbGeAlD
Nicotine—CYP2E1—medulla oblongata—multiple sclerosis	0.000319	0.00252	CbGeAlD
Nicotine—SLC22A3—brain—multiple sclerosis	0.000309	0.00244	CbGeAlD
Nicotine—MAOA—central nervous system—multiple sclerosis	0.000308	0.00243	CbGeAlD
Nicotine—CYP19A1—brain—multiple sclerosis	0.000304	0.0024	CbGeAlD
Nicotine—MAOA—cerebellum—multiple sclerosis	0.000301	0.00238	CbGeAlD
Nicotine—MAOB—brain—multiple sclerosis	0.000286	0.00226	CbGeAlD
Nicotine—CYP2E1—spinal cord—multiple sclerosis	0.000285	0.00225	CbGeAlD
Nicotine—SLC22A5—cerebellum—multiple sclerosis	0.000277	0.00219	CbGeAlD
Nicotine—CYP1A1—nervous system—multiple sclerosis	0.000263	0.00208	CbGeAlD
Nicotine—CYP2B6—nervous system—multiple sclerosis	0.000256	0.00202	CbGeAlD
Nicotine—CYP1A1—central nervous system—multiple sclerosis	0.000253	0.002	CbGeAlD
Nicotine—CYP2B6—central nervous system—multiple sclerosis	0.000246	0.00194	CbGeAlD
Nicotine—MAOA—brain—multiple sclerosis	0.000244	0.00193	CbGeAlD
Nicotine—CYP2E1—nervous system—multiple sclerosis	0.00024	0.00189	CbGeAlD
Nicotine—CYP2E1—central nervous system—multiple sclerosis	0.000231	0.00182	CbGeAlD
Nicotine—CYP2E1—cerebellum—multiple sclerosis	0.000226	0.00178	CbGeAlD
Nicotine—SLC22A5—brain—multiple sclerosis	0.000225	0.00178	CbGeAlD
Nicotine—CYP2C8—brain—multiple sclerosis	0.000218	0.00172	CbGeAlD
Nicotine—CYP1A1—brain—multiple sclerosis	0.000201	0.00159	CbGeAlD
Nicotine—CYP2B6—brain—multiple sclerosis	0.000195	0.00154	CbGeAlD
Nicotine—CYP3A4—nervous system—multiple sclerosis	0.000193	0.00152	CbGeAlD
Nicotine—CYP2D6—nervous system—multiple sclerosis	0.00019	0.0015	CbGeAlD
Nicotine—CYP3A4—central nervous system—multiple sclerosis	0.000186	0.00147	CbGeAlD
Nicotine—CYP2E1—brain—multiple sclerosis	0.000183	0.00145	CbGeAlD
Nicotine—Myalgia—Methylprednisolone—multiple sclerosis	0.000183	0.00116	CcSEcCtD
Nicotine—CYP2D6—central nervous system—multiple sclerosis	0.000183	0.00144	CbGeAlD
Nicotine—Anxiety—Methylprednisolone—multiple sclerosis	0.000183	0.00116	CcSEcCtD
Nicotine—Rash—Azathioprine—multiple sclerosis	0.000182	0.00115	CcSEcCtD
Nicotine—Dermatitis—Azathioprine—multiple sclerosis	0.000182	0.00115	CcSEcCtD
Nicotine—Flushing—Prednisone—multiple sclerosis	0.000182	0.00115	CcSEcCtD
Nicotine—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000182	0.00115	CcSEcCtD
Nicotine—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000182	0.00115	CcSEcCtD
Nicotine—Discomfort—Triamcinolone—multiple sclerosis	0.000182	0.00115	CcSEcCtD
Nicotine—Discomfort—Methylprednisolone—multiple sclerosis	0.000181	0.00115	CcSEcCtD
Nicotine—Headache—Azathioprine—multiple sclerosis	0.000181	0.00115	CcSEcCtD
Nicotine—Dry mouth—Triamcinolone—multiple sclerosis	0.00018	0.00114	CcSEcCtD
Nicotine—Angioedema—Betamethasone—multiple sclerosis	0.000179	0.00113	CcSEcCtD
Nicotine—Angioedema—Dexamethasone—multiple sclerosis	0.000179	0.00113	CcSEcCtD
Nicotine—CYP2D6—cerebellum—multiple sclerosis	0.000179	0.00141	CbGeAlD
Nicotine—Stomatitis—Methotrexate—multiple sclerosis	0.000178	0.00113	CcSEcCtD
Nicotine—Confusional state—Methylprednisolone—multiple sclerosis	0.000177	0.00112	CcSEcCtD
Nicotine—Immune system disorder—Prednisone—multiple sclerosis	0.000177	0.00112	CcSEcCtD
Nicotine—Malaise—Betamethasone—multiple sclerosis	0.000177	0.00112	CcSEcCtD
Nicotine—Malaise—Dexamethasone—multiple sclerosis	0.000177	0.00112	CcSEcCtD
Nicotine—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000176	0.00112	CcSEcCtD
Nicotine—Oedema—Triamcinolone—multiple sclerosis	0.000176	0.00112	CcSEcCtD
Nicotine—Vertigo—Dexamethasone—multiple sclerosis	0.000176	0.00112	CcSEcCtD
Nicotine—Vertigo—Betamethasone—multiple sclerosis	0.000176	0.00112	CcSEcCtD
Nicotine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000176	0.00111	CcSEcCtD
Nicotine—Syncope—Dexamethasone—multiple sclerosis	0.000176	0.00111	CcSEcCtD
Nicotine—Syncope—Betamethasone—multiple sclerosis	0.000176	0.00111	CcSEcCtD
Nicotine—Arrhythmia—Prednisone—multiple sclerosis	0.000175	0.00111	CcSEcCtD
Nicotine—Shock—Triamcinolone—multiple sclerosis	0.000173	0.0011	CcSEcCtD
Nicotine—Insomnia—Prednisolone—multiple sclerosis	0.000173	0.0011	CcSEcCtD
Nicotine—Shock—Methylprednisolone—multiple sclerosis	0.000173	0.0011	CcSEcCtD
Nicotine—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000172	0.00109	CcSEcCtD
Nicotine—Loss of consciousness—Betamethasone—multiple sclerosis	0.000172	0.00109	CcSEcCtD
Nicotine—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000172	0.00109	CcSEcCtD
Nicotine—Epistaxis—Methotrexate—multiple sclerosis	0.000172	0.00109	CcSEcCtD
Nicotine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000172	0.00109	CcSEcCtD
Nicotine—Paraesthesia—Prednisolone—multiple sclerosis	0.000172	0.00109	CcSEcCtD
Nicotine—Tachycardia—Triamcinolone—multiple sclerosis	0.000172	0.00109	CcSEcCtD
Nicotine—Mental disorder—Prednisone—multiple sclerosis	0.000172	0.00109	CcSEcCtD
Nicotine—Nausea—Azathioprine—multiple sclerosis	0.000172	0.00109	CcSEcCtD
Nicotine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000172	0.00109	CcSEcCtD
Nicotine—Erythema—Prednisone—multiple sclerosis	0.000171	0.00108	CcSEcCtD
Nicotine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.00017	0.00108	CcSEcCtD
Nicotine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.00017	0.00108	CcSEcCtD
Nicotine—Convulsion—Betamethasone—multiple sclerosis	0.00017	0.00108	CcSEcCtD
Nicotine—Convulsion—Dexamethasone—multiple sclerosis	0.00017	0.00108	CcSEcCtD
Nicotine—Hypertension—Betamethasone—multiple sclerosis	0.000169	0.00107	CcSEcCtD
Nicotine—Hypertension—Dexamethasone—multiple sclerosis	0.000169	0.00107	CcSEcCtD
Nicotine—Asthenia—Mitoxantrone—multiple sclerosis	0.000168	0.00106	CcSEcCtD
Nicotine—Myalgia—Betamethasone—multiple sclerosis	0.000167	0.00106	CcSEcCtD
Nicotine—Myalgia—Dexamethasone—multiple sclerosis	0.000167	0.00106	CcSEcCtD
Nicotine—Anxiety—Betamethasone—multiple sclerosis	0.000166	0.00105	CcSEcCtD
Nicotine—Anxiety—Dexamethasone—multiple sclerosis	0.000166	0.00105	CcSEcCtD
Nicotine—Discomfort—Dexamethasone—multiple sclerosis	0.000165	0.00104	CcSEcCtD
Nicotine—Discomfort—Betamethasone—multiple sclerosis	0.000165	0.00104	CcSEcCtD
Nicotine—Hypotension—Methylprednisolone—multiple sclerosis	0.000164	0.00104	CcSEcCtD
Nicotine—Pain—Prednisolone—multiple sclerosis	0.000164	0.00104	CcSEcCtD
Nicotine—Pharyngitis—Methotrexate—multiple sclerosis	0.000163	0.00103	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.00016	0.00102	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.00016	0.00102	CcSEcCtD
Nicotine—Anaphylactic shock—Betamethasone—multiple sclerosis	0.00016	0.00101	CcSEcCtD
Nicotine—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.00016	0.00101	CcSEcCtD
Nicotine—Oedema—Betamethasone—multiple sclerosis	0.00016	0.00101	CcSEcCtD
Nicotine—Oedema—Dexamethasone—multiple sclerosis	0.00016	0.00101	CcSEcCtD
Nicotine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00016	0.00101	CcSEcCtD
Nicotine—Insomnia—Triamcinolone—multiple sclerosis	0.000159	0.00101	CcSEcCtD
Nicotine—Insomnia—Methylprednisolone—multiple sclerosis	0.000159	0.00101	CcSEcCtD
Nicotine—Ill-defined disorder—Prednisone—multiple sclerosis	0.000158	0.001	CcSEcCtD
Nicotine—Paraesthesia—Triamcinolone—multiple sclerosis	0.000158	0.001	CcSEcCtD
Nicotine—Feeling abnormal—Prednisolone—multiple sclerosis	0.000158	0.001	CcSEcCtD
Nicotine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000158	0.001	CcSEcCtD
Nicotine—Visual impairment—Methotrexate—multiple sclerosis	0.000158	0.001	CcSEcCtD
Nicotine—Shock—Betamethasone—multiple sclerosis	0.000157	0.000997	CcSEcCtD
Nicotine—Shock—Dexamethasone—multiple sclerosis	0.000157	0.000997	CcSEcCtD
Nicotine—Dyspnoea—Triamcinolone—multiple sclerosis	0.000157	0.000996	CcSEcCtD
Nicotine—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000157	0.000994	CcSEcCtD
Nicotine—Nervous system disorder—Betamethasone—multiple sclerosis	0.000157	0.000994	CcSEcCtD
Nicotine—Agitation—Prednisone—multiple sclerosis	0.000157	0.000994	CcSEcCtD
Nicotine—Tachycardia—Betamethasone—multiple sclerosis	0.000156	0.000989	CcSEcCtD
Nicotine—Tachycardia—Dexamethasone—multiple sclerosis	0.000156	0.000989	CcSEcCtD
Nicotine—Angioedema—Prednisone—multiple sclerosis	0.000156	0.000988	CcSEcCtD
Nicotine—Dyspepsia—Triamcinolone—multiple sclerosis	0.000155	0.000983	CcSEcCtD
Nicotine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000155	0.000981	CcSEcCtD
Nicotine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000155	0.00098	CcSEcCtD
Nicotine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000155	0.00098	CcSEcCtD
Nicotine—Malaise—Prednisone—multiple sclerosis	0.000154	0.000975	CcSEcCtD
Nicotine—Vertigo—Prednisone—multiple sclerosis	0.000153	0.000972	CcSEcCtD
Nicotine—Syncope—Prednisone—multiple sclerosis	0.000153	0.00097	CcSEcCtD
Nicotine—Urticaria—Prednisolone—multiple sclerosis	0.000152	0.000965	CcSEcCtD
Nicotine—Cardiac disorder—Methotrexate—multiple sclerosis	0.000152	0.000964	CcSEcCtD
Nicotine—Fatigue—Triamcinolone—multiple sclerosis	0.000152	0.000963	CcSEcCtD
Nicotine—Fatigue—Methylprednisolone—multiple sclerosis	0.000152	0.000961	CcSEcCtD
Nicotine—Pain—Triamcinolone—multiple sclerosis	0.000151	0.000955	CcSEcCtD
Nicotine—Loss of consciousness—Prednisone—multiple sclerosis	0.00015	0.00095	CcSEcCtD
Nicotine—Hypotension—Dexamethasone—multiple sclerosis	0.000149	0.000947	CcSEcCtD
Nicotine—Hypotension—Betamethasone—multiple sclerosis	0.000149	0.000947	CcSEcCtD
Nicotine—Vomiting—Mitoxantrone—multiple sclerosis	0.000148	0.000941	CcSEcCtD
Nicotine—Immune system disorder—Methotrexate—multiple sclerosis	0.000148	0.000938	CcSEcCtD
Nicotine—Convulsion—Prednisone—multiple sclerosis	0.000148	0.000937	CcSEcCtD
Nicotine—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000148	0.000936	CcSEcCtD
Nicotine—Hypertension—Prednisone—multiple sclerosis	0.000147	0.000934	CcSEcCtD
Nicotine—Rash—Mitoxantrone—multiple sclerosis	0.000147	0.000933	CcSEcCtD
Nicotine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000147	0.000933	CcSEcCtD
Nicotine—Headache—Mitoxantrone—multiple sclerosis	0.000146	0.000927	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000146	0.000923	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000146	0.000923	CcSEcCtD
Nicotine—CYP2D6—brain—multiple sclerosis	0.000145	0.00115	CbGeAlD
Nicotine—Arthralgia—Prednisone—multiple sclerosis	0.000145	0.000921	CcSEcCtD
Nicotine—Myalgia—Prednisone—multiple sclerosis	0.000145	0.000921	CcSEcCtD
Nicotine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000145	0.00092	CcSEcCtD
Nicotine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000145	0.000918	CcSEcCtD
Nicotine—Anxiety—Prednisone—multiple sclerosis	0.000145	0.000917	CcSEcCtD
Nicotine—Insomnia—Betamethasone—multiple sclerosis	0.000145	0.000917	CcSEcCtD
Nicotine—Insomnia—Dexamethasone—multiple sclerosis	0.000145	0.000917	CcSEcCtD
Nicotine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000144	0.000911	CcSEcCtD
Nicotine—Paraesthesia—Betamethasone—multiple sclerosis	0.000144	0.00091	CcSEcCtD
Nicotine—Paraesthesia—Dexamethasone—multiple sclerosis	0.000144	0.00091	CcSEcCtD
Nicotine—Discomfort—Prednisone—multiple sclerosis	0.000143	0.00091	CcSEcCtD
Nicotine—Mental disorder—Methotrexate—multiple sclerosis	0.000143	0.00091	CcSEcCtD
Nicotine—Erythema—Methotrexate—multiple sclerosis	0.000143	0.000904	CcSEcCtD
Nicotine—Hypersensitivity—Prednisolone—multiple sclerosis	0.000141	0.000895	CcSEcCtD
Nicotine—Dyspepsia—Dexamethasone—multiple sclerosis	0.000141	0.000892	CcSEcCtD
Nicotine—Dyspepsia—Betamethasone—multiple sclerosis	0.000141	0.000892	CcSEcCtD
Nicotine—Urticaria—Triamcinolone—multiple sclerosis	0.00014	0.000887	CcSEcCtD
Nicotine—Urticaria—Methylprednisolone—multiple sclerosis	0.00014	0.000885	CcSEcCtD
Nicotine—Dysgeusia—Methotrexate—multiple sclerosis	0.00014	0.000885	CcSEcCtD
Nicotine—Body temperature increased—Triamcinolone—multiple sclerosis	0.000139	0.000883	CcSEcCtD
Nicotine—Anaphylactic shock—Prednisone—multiple sclerosis	0.000139	0.000883	CcSEcCtD
Nicotine—Oedema—Prednisone—multiple sclerosis	0.000139	0.000883	CcSEcCtD
Nicotine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000139	0.000881	CcSEcCtD
Nicotine—Nausea—Mitoxantrone—multiple sclerosis	0.000139	0.000879	CcSEcCtD
Nicotine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000138	0.000875	CcSEcCtD
Nicotine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000138	0.000875	CcSEcCtD
Nicotine—Back pain—Methotrexate—multiple sclerosis	0.000138	0.000874	CcSEcCtD
Nicotine—Fatigue—Betamethasone—multiple sclerosis	0.000138	0.000874	CcSEcCtD
Nicotine—Fatigue—Dexamethasone—multiple sclerosis	0.000138	0.000874	CcSEcCtD
Nicotine—Shock—Prednisone—multiple sclerosis	0.000137	0.000868	CcSEcCtD
Nicotine—Pain—Dexamethasone—multiple sclerosis	0.000137	0.000867	CcSEcCtD
Nicotine—Pain—Betamethasone—multiple sclerosis	0.000137	0.000867	CcSEcCtD
Nicotine—Nervous system disorder—Prednisone—multiple sclerosis	0.000136	0.000866	CcSEcCtD
Nicotine—Tachycardia—Prednisone—multiple sclerosis	0.000136	0.000861	CcSEcCtD
Nicotine—Hyperhidrosis—Prednisone—multiple sclerosis	0.000135	0.000853	CcSEcCtD
Nicotine—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000132	0.000839	CcSEcCtD
Nicotine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000132	0.000835	CcSEcCtD
Nicotine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000132	0.000835	CcSEcCtD
Nicotine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000131	0.000829	CcSEcCtD
Nicotine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000131	0.000829	CcSEcCtD
Nicotine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00013	0.000823	CcSEcCtD
Nicotine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000129	0.000821	CcSEcCtD
Nicotine—Malaise—Methotrexate—multiple sclerosis	0.000129	0.000815	CcSEcCtD
Nicotine—Vertigo—Methotrexate—multiple sclerosis	0.000128	0.000812	CcSEcCtD
Nicotine—Urticaria—Dexamethasone—multiple sclerosis	0.000127	0.000805	CcSEcCtD
Nicotine—Urticaria—Betamethasone—multiple sclerosis	0.000127	0.000805	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000127	0.000804	CcSEcCtD
Nicotine—Dizziness—Prednisolone—multiple sclerosis	0.000127	0.000803	CcSEcCtD
Nicotine—Asthenia—Triamcinolone—multiple sclerosis	0.000126	0.000801	CcSEcCtD
Nicotine—Abdominal pain—Betamethasone—multiple sclerosis	0.000126	0.000801	CcSEcCtD
Nicotine—Body temperature increased—Betamethasone—multiple sclerosis	0.000126	0.000801	CcSEcCtD
Nicotine—Body temperature increased—Dexamethasone—multiple sclerosis	0.000126	0.000801	CcSEcCtD
Nicotine—Abdominal pain—Dexamethasone—multiple sclerosis	0.000126	0.000801	CcSEcCtD
Nicotine—Asthenia—Methylprednisolone—multiple sclerosis	0.000126	0.0008	CcSEcCtD
Nicotine—Insomnia—Prednisone—multiple sclerosis	0.000126	0.000798	CcSEcCtD
Nicotine—Paraesthesia—Prednisone—multiple sclerosis	0.000125	0.000792	CcSEcCtD
Nicotine—Pruritus—Triamcinolone—multiple sclerosis	0.000125	0.00079	CcSEcCtD
Nicotine—Cough—Methotrexate—multiple sclerosis	0.000124	0.000789	CcSEcCtD
Nicotine—Pruritus—Methylprednisolone—multiple sclerosis	0.000124	0.000788	CcSEcCtD
Nicotine—Convulsion—Methotrexate—multiple sclerosis	0.000123	0.000783	CcSEcCtD
Nicotine—Dyspepsia—Prednisone—multiple sclerosis	0.000123	0.000777	CcSEcCtD
Nicotine—Myalgia—Methotrexate—multiple sclerosis	0.000121	0.000769	CcSEcCtD
Nicotine—Chest pain—Methotrexate—multiple sclerosis	0.000121	0.000769	CcSEcCtD
Nicotine—Arthralgia—Methotrexate—multiple sclerosis	0.000121	0.000769	CcSEcCtD
Nicotine—Rash—Prednisolone—multiple sclerosis	0.000121	0.000766	CcSEcCtD
Nicotine—Dermatitis—Prednisolone—multiple sclerosis	0.000121	0.000765	CcSEcCtD
Nicotine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.00012	0.000762	CcSEcCtD
Nicotine—Fatigue—Prednisone—multiple sclerosis	0.00012	0.000761	CcSEcCtD
Nicotine—Headache—Prednisolone—multiple sclerosis	0.00012	0.000761	CcSEcCtD
Nicotine—Discomfort—Methotrexate—multiple sclerosis	0.00012	0.00076	CcSEcCtD
Nicotine—Constipation—Prednisone—multiple sclerosis	0.000119	0.000755	CcSEcCtD
Nicotine—Confusional state—Methotrexate—multiple sclerosis	0.000117	0.000744	CcSEcCtD
Nicotine—Dizziness—Triamcinolone—multiple sclerosis	0.000116	0.000739	CcSEcCtD
Nicotine—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000116	0.000738	CcSEcCtD
Nicotine—Dizziness—Methylprednisolone—multiple sclerosis	0.000116	0.000737	CcSEcCtD
Nicotine—Feeling abnormal—Prednisone—multiple sclerosis	0.000115	0.000727	CcSEcCtD
Nicotine—Asthenia—Betamethasone—multiple sclerosis	0.000115	0.000727	CcSEcCtD
Nicotine—Asthenia—Dexamethasone—multiple sclerosis	0.000115	0.000727	CcSEcCtD
Nicotine—Nervous system disorder—Methotrexate—multiple sclerosis	0.000114	0.000723	CcSEcCtD
Nicotine—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000114	0.000722	CcSEcCtD
Nicotine—Nausea—Prednisolone—multiple sclerosis	0.000114	0.000721	CcSEcCtD
Nicotine—Pruritus—Dexamethasone—multiple sclerosis	0.000113	0.000717	CcSEcCtD
Nicotine—Pruritus—Betamethasone—multiple sclerosis	0.000113	0.000717	CcSEcCtD
Nicotine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000112	0.000713	CcSEcCtD
Nicotine—Vomiting—Triamcinolone—multiple sclerosis	0.000112	0.00071	CcSEcCtD
Nicotine—Vomiting—Methylprednisolone—multiple sclerosis	0.000112	0.000709	CcSEcCtD
Nicotine—Rash—Triamcinolone—multiple sclerosis	0.000111	0.000704	CcSEcCtD
Nicotine—Dermatitis—Triamcinolone—multiple sclerosis	0.000111	0.000704	CcSEcCtD
Nicotine—Rash—Methylprednisolone—multiple sclerosis	0.000111	0.000703	CcSEcCtD
Nicotine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000111	0.000702	CcSEcCtD
Nicotine—Urticaria—Prednisone—multiple sclerosis	0.000111	0.000701	CcSEcCtD
Nicotine—Headache—Triamcinolone—multiple sclerosis	0.00011	0.0007	CcSEcCtD
Nicotine—Headache—Methylprednisolone—multiple sclerosis	0.00011	0.000698	CcSEcCtD
Nicotine—Abdominal pain—Prednisone—multiple sclerosis	0.00011	0.000698	CcSEcCtD
Nicotine—Body temperature increased—Prednisone—multiple sclerosis	0.00011	0.000698	CcSEcCtD
Nicotine—Diarrhoea—Betamethasone—multiple sclerosis	0.000109	0.000693	CcSEcCtD
Nicotine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000109	0.000693	CcSEcCtD
Nicotine—Hypotension—Methotrexate—multiple sclerosis	0.000109	0.000689	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000106	0.000672	CcSEcCtD
Nicotine—Dizziness—Dexamethasone—multiple sclerosis	0.000106	0.00067	CcSEcCtD
Nicotine—Dizziness—Betamethasone—multiple sclerosis	0.000106	0.00067	CcSEcCtD
Nicotine—Insomnia—Methotrexate—multiple sclerosis	0.000105	0.000667	CcSEcCtD
Nicotine—Nausea—Triamcinolone—multiple sclerosis	0.000105	0.000663	CcSEcCtD
Nicotine—Paraesthesia—Methotrexate—multiple sclerosis	0.000104	0.000662	CcSEcCtD
Nicotine—Nausea—Methylprednisolone—multiple sclerosis	0.000104	0.000662	CcSEcCtD
Nicotine—Dyspnoea—Methotrexate—multiple sclerosis	0.000104	0.000658	CcSEcCtD
Nicotine—Somnolence—Methotrexate—multiple sclerosis	0.000103	0.000656	CcSEcCtD
Nicotine—Hypersensitivity—Prednisone—multiple sclerosis	0.000103	0.00065	CcSEcCtD
Nicotine—Dyspepsia—Methotrexate—multiple sclerosis	0.000102	0.000649	CcSEcCtD
Nicotine—Vomiting—Dexamethasone—multiple sclerosis	0.000102	0.000644	CcSEcCtD
Nicotine—Vomiting—Betamethasone—multiple sclerosis	0.000102	0.000644	CcSEcCtD
Nicotine—Rash—Dexamethasone—multiple sclerosis	0.000101	0.000639	CcSEcCtD
Nicotine—Rash—Betamethasone—multiple sclerosis	0.000101	0.000639	CcSEcCtD
Nicotine—Dermatitis—Dexamethasone—multiple sclerosis	0.000101	0.000638	CcSEcCtD
Nicotine—Dermatitis—Betamethasone—multiple sclerosis	0.000101	0.000638	CcSEcCtD
Nicotine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.0001	0.000637	CcSEcCtD
Nicotine—Fatigue—Methotrexate—multiple sclerosis	0.0001	0.000636	CcSEcCtD
Nicotine—Headache—Betamethasone—multiple sclerosis	0.0001	0.000635	CcSEcCtD
Nicotine—Headache—Dexamethasone—multiple sclerosis	0.0001	0.000635	CcSEcCtD
Nicotine—Asthenia—Prednisone—multiple sclerosis	9.99e-05	0.000633	CcSEcCtD
Nicotine—Pain—Methotrexate—multiple sclerosis	9.95e-05	0.000631	CcSEcCtD
Nicotine—Pruritus—Prednisone—multiple sclerosis	9.85e-05	0.000624	CcSEcCtD
Nicotine—Feeling abnormal—Methotrexate—multiple sclerosis	9.59e-05	0.000608	CcSEcCtD
Nicotine—Diarrhoea—Prednisone—multiple sclerosis	9.52e-05	0.000604	CcSEcCtD
Nicotine—Gastrointestinal pain—Methotrexate—multiple sclerosis	9.51e-05	0.000603	CcSEcCtD
Nicotine—Nausea—Betamethasone—multiple sclerosis	9.49e-05	0.000602	CcSEcCtD
Nicotine—Nausea—Dexamethasone—multiple sclerosis	9.49e-05	0.000602	CcSEcCtD
Nicotine—Urticaria—Methotrexate—multiple sclerosis	9.24e-05	0.000586	CcSEcCtD
Nicotine—Dizziness—Prednisone—multiple sclerosis	9.2e-05	0.000584	CcSEcCtD
Nicotine—Body temperature increased—Methotrexate—multiple sclerosis	9.2e-05	0.000583	CcSEcCtD
Nicotine—Abdominal pain—Methotrexate—multiple sclerosis	9.2e-05	0.000583	CcSEcCtD
Nicotine—Vomiting—Prednisone—multiple sclerosis	8.85e-05	0.000561	CcSEcCtD
Nicotine—Rash—Prednisone—multiple sclerosis	8.78e-05	0.000556	CcSEcCtD
Nicotine—Dermatitis—Prednisone—multiple sclerosis	8.77e-05	0.000556	CcSEcCtD
Nicotine—Headache—Prednisone—multiple sclerosis	8.72e-05	0.000553	CcSEcCtD
Nicotine—Hypersensitivity—Methotrexate—multiple sclerosis	8.57e-05	0.000543	CcSEcCtD
Nicotine—Asthenia—Methotrexate—multiple sclerosis	8.35e-05	0.000529	CcSEcCtD
Nicotine—Nausea—Prednisone—multiple sclerosis	8.27e-05	0.000524	CcSEcCtD
Nicotine—Pruritus—Methotrexate—multiple sclerosis	8.23e-05	0.000522	CcSEcCtD
Nicotine—Diarrhoea—Methotrexate—multiple sclerosis	7.96e-05	0.000505	CcSEcCtD
Nicotine—Dizziness—Methotrexate—multiple sclerosis	7.69e-05	0.000488	CcSEcCtD
Nicotine—Vomiting—Methotrexate—multiple sclerosis	7.4e-05	0.000469	CcSEcCtD
Nicotine—Rash—Methotrexate—multiple sclerosis	7.33e-05	0.000465	CcSEcCtD
Nicotine—Dermatitis—Methotrexate—multiple sclerosis	7.33e-05	0.000465	CcSEcCtD
Nicotine—Headache—Methotrexate—multiple sclerosis	7.29e-05	0.000462	CcSEcCtD
Nicotine—Nausea—Methotrexate—multiple sclerosis	6.91e-05	0.000438	CcSEcCtD
Nicotine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.39e-05	0.000508	CbGpPWpGaD
Nicotine—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.34e-05	0.000504	CbGpPWpGaD
Nicotine—MAOA—Biological oxidations—POMC—multiple sclerosis	5.33e-05	0.000503	CbGpPWpGaD
Nicotine—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.32e-05	0.000502	CbGpPWpGaD
Nicotine—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	5.29e-05	0.000499	CbGpPWpGaD
Nicotine—CHRNB4—SIDS Susceptibility Pathways—IL6—multiple sclerosis	5.26e-05	0.000497	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.26e-05	0.000496	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.26e-05	0.000496	CbGpPWpGaD
Nicotine—CYP19A1—Biological oxidations—POMC—multiple sclerosis	5.2e-05	0.00049	CbGpPWpGaD
Nicotine—CHRNA3—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	5.14e-05	0.000484	CbGpPWpGaD
Nicotine—CYP1A1—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	5.12e-05	0.000483	CbGpPWpGaD
Nicotine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	5.1e-05	0.000481	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—BCHE—multiple sclerosis	5.1e-05	0.000481	CbGpPWpGaD
Nicotine—CYP1A1—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	5.01e-05	0.000472	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—GPC5—multiple sclerosis	5e-05	0.000471	CbGpPWpGaD
Nicotine—MAOB—Metabolism—RRM1—multiple sclerosis	4.89e-05	0.000461	CbGpPWpGaD
Nicotine—CHRNA7—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	4.87e-05	0.00046	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—SRM—multiple sclerosis	4.86e-05	0.000459	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.82e-05	0.000455	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.82e-05	0.000455	CbGpPWpGaD
Nicotine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	4.77e-05	0.00045	CbGpPWpGaD
Nicotine—CYP1A1—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	4.77e-05	0.00045	CbGpPWpGaD
Nicotine—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.75e-05	0.000448	CbGpPWpGaD
Nicotine—SLC22A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.71e-05	0.000445	CbGpPWpGaD
Nicotine—SLC22A3—SLC-mediated transmembrane transport—ALB—multiple sclerosis	4.71e-05	0.000444	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	4.7e-05	0.000443	CbGpPWpGaD
Nicotine—SLC22A5—SLC-mediated transmembrane transport—ALB—multiple sclerosis	4.69e-05	0.000442	CbGpPWpGaD
Nicotine—CHRNA4—SIDS Susceptibility Pathways—TNF—multiple sclerosis	4.62e-05	0.000435	CbGpPWpGaD
Nicotine—CHRNA2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	4.58e-05	0.000432	CbGpPWpGaD
Nicotine—CHRNA7—SIDS Susceptibility Pathways—IL6—multiple sclerosis	4.57e-05	0.000431	CbGpPWpGaD
Nicotine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.56e-05	0.00043	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—SRM—multiple sclerosis	4.53e-05	0.000427	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—SRM—multiple sclerosis	4.46e-05	0.000421	CbGpPWpGaD
Nicotine—SLC22A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.39e-05	0.000414	CbGpPWpGaD
Nicotine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.37e-05	0.000412	CbGpPWpGaD
Nicotine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.33e-05	0.000408	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.31e-05	0.000406	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.31e-05	0.000406	CbGpPWpGaD
Nicotine—CHRNB4—Neuronal System—MAPK1—multiple sclerosis	4.3e-05	0.000406	CbGpPWpGaD
Nicotine—MAOA—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	4.28e-05	0.000403	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	4.19e-05	0.000395	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	4.17e-05	0.000394	CbGpPWpGaD
Nicotine—SLC22A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.17e-05	0.000393	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—RRM1—multiple sclerosis	4.14e-05	0.00039	CbGpPWpGaD
Nicotine—CYP2A6—Biological oxidations—POMC—multiple sclerosis	4.14e-05	0.00039	CbGpPWpGaD
Nicotine—MAOA—Metabolism—CYP27B1—multiple sclerosis	4.05e-05	0.000382	CbGpPWpGaD
Nicotine—MAOA—Metabolism—CYP24A1—multiple sclerosis	4.05e-05	0.000382	CbGpPWpGaD
Nicotine—CHRNA4—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	3.97e-05	0.000375	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—CYP27B1—multiple sclerosis	3.95e-05	0.000373	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—CYP24A1—multiple sclerosis	3.95e-05	0.000373	CbGpPWpGaD
Nicotine—CHRNA3—Neuronal System—MAPK1—multiple sclerosis	3.94e-05	0.000371	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.93e-05	0.00037	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.93e-05	0.00037	CbGpPWpGaD
Nicotine—SLC22A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.88e-05	0.000366	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.86e-05	0.000364	CbGpPWpGaD
Nicotine—CHRNA7—Neuronal System—MAPK1—multiple sclerosis	3.73e-05	0.000352	CbGpPWpGaD
Nicotine—CHRNA4—SIDS Susceptibility Pathways—IL6—multiple sclerosis	3.72e-05	0.000351	CbGpPWpGaD
Nicotine—MAOA—Metabolism—GPC5—multiple sclerosis	3.7e-05	0.000349	CbGpPWpGaD
Nicotine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.7e-05	0.000349	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—GPC5—multiple sclerosis	3.61e-05	0.000341	CbGpPWpGaD
Nicotine—CHAT—Metabolism—APOE—multiple sclerosis	3.61e-05	0.000341	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—SRM—multiple sclerosis	3.6e-05	0.00034	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—SRM—multiple sclerosis	3.53e-05	0.000333	CbGpPWpGaD
Nicotine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.52e-05	0.000332	CbGpPWpGaD
Nicotine—CHRNA2—Neuronal System—MAPK1—multiple sclerosis	3.51e-05	0.000331	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—CYP24A1—multiple sclerosis	3.43e-05	0.000323	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—CYP27B1—multiple sclerosis	3.43e-05	0.000323	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.35e-05	0.000316	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.35e-05	0.000316	CbGpPWpGaD
Nicotine—CYP2B6—Biological oxidations—POMC—multiple sclerosis	3.34e-05	0.000315	CbGpPWpGaD
Nicotine—CYP19A1—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	3.33e-05	0.000314	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—SRM—multiple sclerosis	3.33e-05	0.000314	CbGpPWpGaD
Nicotine—CYP2E1—Biological oxidations—POMC—multiple sclerosis	3.27e-05	0.000308	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	3.26e-05	0.000308	CbGpPWpGaD
Nicotine—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	3.26e-05	0.000308	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	3.25e-05	0.000307	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—CYP27B1—multiple sclerosis	3.19e-05	0.000301	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—CYP24A1—multiple sclerosis	3.19e-05	0.000301	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	3.19e-05	0.000301	CbGpPWpGaD
Nicotine—SLC22A4—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.17e-05	0.000299	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—CYP24A1—multiple sclerosis	3.14e-05	0.000297	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—CYP27B1—multiple sclerosis	3.14e-05	0.000297	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—GPC5—multiple sclerosis	3.13e-05	0.000296	CbGpPWpGaD
Nicotine—MAOA—SIDS Susceptibility Pathways—TNF—multiple sclerosis	3.1e-05	0.000293	CbGpPWpGaD
Nicotine—CHAT—Metabolism—POMC—multiple sclerosis	3.1e-05	0.000293	CbGpPWpGaD
Nicotine—CYP1A1—Biological oxidations—POMC—multiple sclerosis	3.08e-05	0.000291	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—APOE—multiple sclerosis	3.07e-05	0.00029	CbGpPWpGaD
Nicotine—MAOA—Metabolism—RRM1—multiple sclerosis	3.07e-05	0.00029	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—SRM—multiple sclerosis	3.05e-05	0.000288	CbGpPWpGaD
Nicotine—CHRNA4—Neuronal System—MAPK1—multiple sclerosis	3.04e-05	0.000287	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	3.04e-05	0.000287	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	3.04e-05	0.000287	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—RRM1—multiple sclerosis	2.99e-05	0.000282	CbGpPWpGaD
Nicotine—SLC22A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	2.95e-05	0.000278	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—GPC5—multiple sclerosis	2.92e-05	0.000275	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—GPC5—multiple sclerosis	2.88e-05	0.000271	CbGpPWpGaD
Nicotine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.86e-05	0.000269	CbGpPWpGaD
Nicotine—CHAT—Metabolism—ALB—multiple sclerosis	2.83e-05	0.000267	CbGpPWpGaD
Nicotine—CYP2C8—Biological oxidations—POMC—multiple sclerosis	2.83e-05	0.000267	CbGpPWpGaD
Nicotine—MAOB—Metabolism—BCHE—multiple sclerosis	2.81e-05	0.000265	CbGpPWpGaD
Nicotine—SLC22A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	2.75e-05	0.00026	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—SRM—multiple sclerosis	2.72e-05	0.000257	CbGpPWpGaD
Nicotine—CYP2A6—NRF2 pathway—TGFB1—multiple sclerosis	2.72e-05	0.000257	CbGpPWpGaD
Nicotine—MAOA—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.67e-05	0.000252	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—POMC—multiple sclerosis	2.64e-05	0.000249	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—RRM1—multiple sclerosis	2.6e-05	0.000245	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	2.54e-05	0.000239	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	2.54e-05	0.000239	CbGpPWpGaD
Nicotine—CYP2C19—Biological oxidations—POMC—multiple sclerosis	2.52e-05	0.000238	CbGpPWpGaD
Nicotine—MAOA—SIDS Susceptibility Pathways—IL6—multiple sclerosis	2.5e-05	0.000236	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—SRM—multiple sclerosis	2.5e-05	0.000236	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—CYP27B1—multiple sclerosis	2.49e-05	0.000234	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—CYP24A1—multiple sclerosis	2.49e-05	0.000234	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—SRM—multiple sclerosis	2.48e-05	0.000234	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—RRM1—multiple sclerosis	2.42e-05	0.000228	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—ALB—multiple sclerosis	2.4e-05	0.000227	CbGpPWpGaD
Nicotine—SLC22A3—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.39e-05	0.000226	CbGpPWpGaD
Nicotine—SLC22A5—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.38e-05	0.000225	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—RRM1—multiple sclerosis	2.38e-05	0.000225	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—BCHE—multiple sclerosis	2.38e-05	0.000224	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—CYP24A1—multiple sclerosis	2.34e-05	0.000221	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—CYP27B1—multiple sclerosis	2.34e-05	0.000221	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.32e-05	0.000219	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—GPC5—multiple sclerosis	2.32e-05	0.000219	CbGpPWpGaD
Nicotine—CYP2D6—Biological oxidations—POMC—multiple sclerosis	2.32e-05	0.000219	CbGpPWpGaD
Nicotine—CYP2C9—Biological oxidations—POMC—multiple sclerosis	2.3e-05	0.000217	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.29e-05	0.000216	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—GPC5—multiple sclerosis	2.27e-05	0.000214	CbGpPWpGaD
Nicotine—SLC22A2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.26e-05	0.000213	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	2.15e-05	0.000203	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	2.15e-05	0.000203	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—GPC5—multiple sclerosis	2.14e-05	0.000202	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—SRM—multiple sclerosis	2.12e-05	0.0002	CbGpPWpGaD
Nicotine—SLC22A1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.11e-05	0.000199	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.1e-05	0.000198	CbGpPWpGaD
Nicotine—MAOA—Neuronal System—MAPK1—multiple sclerosis	2.05e-05	0.000193	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2e-05	0.000188	CbGpPWpGaD
Nicotine—CYP1A2—Biological oxidations—POMC—multiple sclerosis	1.97e-05	0.000185	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—GPC5—multiple sclerosis	1.96e-05	0.000185	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—RRM1—multiple sclerosis	1.92e-05	0.000181	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	1.92e-05	0.000181	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	1.92e-05	0.000181	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—RRM1—multiple sclerosis	1.88e-05	0.000178	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.87e-05	0.000177	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.82e-05	0.000172	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—RRM1—multiple sclerosis	1.78e-05	0.000167	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	1.76e-05	0.000166	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	1.76e-05	0.000166	CbGpPWpGaD
Nicotine—MAOA—Metabolism—BCHE—multiple sclerosis	1.76e-05	0.000166	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—GPC5—multiple sclerosis	1.75e-05	0.000165	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	1.75e-05	0.000165	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	1.75e-05	0.000165	CbGpPWpGaD
Nicotine—SLC22A2—Neuronal System—MAPK1—multiple sclerosis	1.73e-05	0.000163	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—BCHE—multiple sclerosis	1.72e-05	0.000162	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.71e-05	0.000161	CbGpPWpGaD
Nicotine—MAOB—Metabolism—APOE—multiple sclerosis	1.69e-05	0.000159	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—SRM—multiple sclerosis	1.64e-05	0.000154	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—RRM1—multiple sclerosis	1.63e-05	0.000154	CbGpPWpGaD
Nicotine—SLC22A1—Neuronal System—MAPK1—multiple sclerosis	1.61e-05	0.000152	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—GPC5—multiple sclerosis	1.61e-05	0.000152	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—GPC5—multiple sclerosis	1.6e-05	0.000151	CbGpPWpGaD
Nicotine—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.52e-05	0.000143	CbGpPWpGaD
Nicotine—SLC22A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.5e-05	0.000141	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	1.49e-05	0.000141	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	1.49e-05	0.000141	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—BCHE—multiple sclerosis	1.49e-05	0.000141	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.46e-05	0.000138	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—RRM1—multiple sclerosis	1.45e-05	0.000137	CbGpPWpGaD
Nicotine—MAOB—Metabolism—POMC—multiple sclerosis	1.45e-05	0.000137	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—APOE—multiple sclerosis	1.43e-05	0.000135	CbGpPWpGaD
Nicotine—SLC22A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.4e-05	0.000132	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—BCHE—multiple sclerosis	1.39e-05	0.000131	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.38e-05	0.00013	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—BCHE—multiple sclerosis	1.37e-05	0.000129	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—GPC5—multiple sclerosis	1.37e-05	0.000129	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—RRM1—multiple sclerosis	1.34e-05	0.000126	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.32e-05	0.000125	CbGpPWpGaD
Nicotine—MAOB—Metabolism—ALB—multiple sclerosis	1.32e-05	0.000125	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.26e-05	0.000119	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—POMC—multiple sclerosis	1.23e-05	0.000116	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.18e-05	0.000112	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.15e-05	0.000109	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.15e-05	0.000109	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.13e-05	0.000107	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.13e-05	0.000106	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—ALB—multiple sclerosis	1.12e-05	0.000106	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—BCHE—multiple sclerosis	1.1e-05	0.000104	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.09e-05	0.000102	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—BCHE—multiple sclerosis	1.08e-05	0.000102	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.08e-05	0.000102	CbGpPWpGaD
Nicotine—MAOA—Metabolism—APOE—multiple sclerosis	1.06e-05	0.0001	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.05e-05	9.95e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—APOE—multiple sclerosis	1.03e-05	9.76e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.03e-05	9.7e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—BCHE—multiple sclerosis	1.02e-05	9.62e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	9.89e-06	9.33e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	9.68e-06	9.13e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—BCHE—multiple sclerosis	9.35e-06	8.82e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—POMC—multiple sclerosis	9.11e-06	8.59e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—APOE—multiple sclerosis	8.97e-06	8.46e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—POMC—multiple sclerosis	8.89e-06	8.38e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	8.83e-06	8.33e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	8.83e-06	8.33e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.78e-06	8.29e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—RRM1—multiple sclerosis	8.74e-06	8.24e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—APOE—multiple sclerosis	8.36e-06	7.89e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—BCHE—multiple sclerosis	8.35e-06	7.87e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—ALB—multiple sclerosis	8.31e-06	7.84e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—APOE—multiple sclerosis	8.23e-06	7.77e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—ALB—multiple sclerosis	8.1e-06	7.64e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	8.05e-06	7.59e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—POMC—multiple sclerosis	7.71e-06	7.27e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—BCHE—multiple sclerosis	7.68e-06	7.24e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—BCHE—multiple sclerosis	7.61e-06	7.18e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.55e-06	7.12e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—POMC—multiple sclerosis	7.18e-06	6.77e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—POMC—multiple sclerosis	7.07e-06	6.67e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—ALB—multiple sclerosis	7.03e-06	6.63e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.88e-06	6.49e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—APOE—multiple sclerosis	6.64e-06	6.27e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—ALB—multiple sclerosis	6.55e-06	6.18e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—APOE—multiple sclerosis	6.51e-06	6.14e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—BCHE—multiple sclerosis	6.5e-06	6.13e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—ALB—multiple sclerosis	6.45e-06	6.08e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—APOE—multiple sclerosis	6.14e-06	5.79e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—POMC—multiple sclerosis	5.71e-06	5.38e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—APOE—multiple sclerosis	5.62e-06	5.31e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—POMC—multiple sclerosis	5.59e-06	5.27e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—POMC—multiple sclerosis	5.27e-06	4.97e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—ALB—multiple sclerosis	5.2e-06	4.91e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—ALB—multiple sclerosis	5.1e-06	4.81e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—APOE—multiple sclerosis	5.02e-06	4.74e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—BCHE—multiple sclerosis	5.02e-06	4.73e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—POMC—multiple sclerosis	4.83e-06	4.56e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—ALB—multiple sclerosis	4.81e-06	4.53e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—APOE—multiple sclerosis	4.62e-06	4.36e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—APOE—multiple sclerosis	4.58e-06	4.32e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—ALB—multiple sclerosis	4.41e-06	4.16e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—POMC—multiple sclerosis	4.31e-06	4.07e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—POMC—multiple sclerosis	3.97e-06	3.74e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—POMC—multiple sclerosis	3.93e-06	3.71e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—ALB—multiple sclerosis	3.93e-06	3.71e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—APOE—multiple sclerosis	3.91e-06	3.69e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—ALB—multiple sclerosis	3.62e-06	3.41e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—ALB—multiple sclerosis	3.59e-06	3.38e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—POMC—multiple sclerosis	3.36e-06	3.17e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—ALB—multiple sclerosis	3.06e-06	2.89e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—APOE—multiple sclerosis	3.02e-06	2.85e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—POMC—multiple sclerosis	2.59e-06	2.45e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—ALB—multiple sclerosis	2.36e-06	2.23e-05	CbGpPWpGaD
